Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026)
Ocular Therapeutix (OCUL) reported Gross Margin of 85.08% for Q2 2026, down 0.48 percentage points from 85.56% a year earlier and down 2.60 percentage points from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's Gross Margin came in at 87.11%, down 2.30 percentage points year-over-year; for FY2025, it was 87.35%, down 3.83 percentage points from FY2024.
- Gross Margin has a five-year change of -0.69 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 91.17% in FY2024 (+0.21 pp), 90.96% in FY2023 (-0.22 pp), 91.18% in FY2022 (+1.31 pp) and 89.88% in FY2021 (+1.85 pp).
- The Q2 2026 figure ranks as the lowest quarterly Gross Margin since Q1 2020.
- Year over year, Gross Margin has now declined in each of the last six quarters, with an average year-over-year change of -1.85 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was Q1 2022 (a gain of 2.29 percentage points); the low point was Q2 2025 (a drop of 5.27 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 87.68% (Q1 2026), 87.97% (Q4 2025) and 87.80% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 85.33% |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 85.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.08% |
| Mar 31, 2026 | 87.68% |
| Dec 31, 2025 | 87.97% |
| Sep 30, 2025 | 87.80% |
| Jun 30, 2025 | 85.56% |
| Mar 31, 2025 | 88.20% |
| Dec 31, 2024 | 92.80% |
| Sep 30, 2024 | 89.88% |
| Jun 30, 2024 | 90.82% |
| Mar 31, 2024 | 91.02% |
| Dec 31, 2023 | 90.64% |
| Sep 30, 2023 | 90.87% |
| Jun 30, 2023 | 91.41% |
| Mar 31, 2023 | 90.92% |
| Dec 31, 2022 | 92.81% |
| Sep 30, 2022 | 91.03% |
| Jun 30, 2022 | 90.58% |
| Mar 31, 2022 | 90.14% |
| Dec 31, 2021 | 91.00% |
| Sep 30, 2021 | 89.22% |
API Access
Ocular Therapeutix Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();